重大创伤骨折应纳入骨折联络服务范围吗:一项成本效益估算
该研究比较了50岁及以上患者轻微创伤(MT)与非轻微创伤(non-MT)骨折后3年再骨折率,并估算将骨折联络服务(FLS)扩展至非MT患者的成本。结果显示MT后再骨折率为8%,非MT为4.5%,非MT约为MT的57%;扩展FLS在2022年将增加直接成本198,326澳元,但若计入再骨折风险降低的名义节省,则基本成本中性。
要点
- 轻微创伤后3年再骨折率为8%,非轻微创伤后为4.5%,非轻微创伤约为轻微创伤的57%。
- 将FLS扩展至非轻微创伤患者增加直接成本198,326澳元,但计入名义节省后基本成本中性。
- 未发现临床可用的入院特征可预测再骨折风险增加。
核心结论
- 非轻微创伤后3年再骨折率约为轻微创伤后再骨折率的一半(57%)。
- 将FLS活动扩展至非轻微创伤患者会产生显著的额外直接成本,但若计入通过降低再骨折风险获得的名义节省,则仍基本成本中性。
研究设计与样本
- 通过亨特新英格兰卫生服务(HNEHS)的综合患者管理系统(IPMS)识别2018年因骨折就诊于约翰·亨特医院的50岁及以上患者,并监测其后3年内向任何HNEHS机构的再次就诊。
- 比较轻微创伤与非轻微创伤就诊者的再骨折率,并使用Cox比例风险回归模型进行分析。
- 通过既往已完成的微观成本分析估算纳入非轻微创伤患者的成本。
- 通过比较两项研究中轻微创伤就诊者的3年再骨折率,确认FLS操作保真度与既往估算一致。
主要发现
- 轻微创伤后3年再骨折率为8%,非轻微创伤后为4.5%。
- 2022年将FLS活动扩展至非轻微创伤患者将额外花费198,326澳元,通过再骨折风险降低带来的名义损失/节省为-26,625/+26,913澳元。
- 未识别出任何临床可用的、在就诊时预测再骨折风险增加的入院特征。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: The refracture rate after major trauma is approximately half (57%) the refracture rate after a minimal trauma injury. Extending Fracture Liaison Service activity to include major trauma patients creates significant additional direct cost, but remains essentially cost neutral if notional savings through refracture risk reduction are taken into account. PURPOSE: To compare the 3-year refracture rate following minimal trauma (MT) and non-minimal trauma (non-MT) injuries and evaluate the cost of extending fracture liaison service (FLS) operations to non-MT presentations. METHODS: Patients aged 50, or above presenting to the John Hunter Hospital with a fracture in calendar year 2018 were identified through the Integrated Patient Management System (IPMS) of the Hunter New England Health Service's (HNEHS), and re-presentation to any HNEHS facility over the following 3 years monitored. The refracture rate of MT and non-MT presentations was compared and analysed using Cox proportional hazards regression models. The cost of including non-MT patients was estimated through the use of a previously conducted micro-costing analysis. The operational fidelity of the FLS to the previous estimate was confirmed by comparing the 3-year refracture rate of MT presentations in the two studies. RESULTS: The 3-year refracture rate following a MT injury was 8% and after non-MT injury 4.5%. Extension of FLS activities to include non-MT patients in 2022 would have cost an additional $198,326 AUD with a notional loss/saving of $ - 26,625/ + 26,913 AUD through refracture risk reduction. No clinically available characteristic at presentation predictive of increased refracture risk was identified. CONCLUSION: The 3-year refracture after a non-MT injury is about half (57%) that of the refracture rate after a MT injury. Extending FLS activity to non-MT patients incurs a significant additional direct cost but remains cost neutral if notional savings gained through reduction in refracture risk are taken into account.
引用
- Chandrasoma D, Chiu S, Niddrie F, et al. Should major trauma fractures be part of a fracture liaison service's remit: a cost-benefit estimate. Osteoporos Int. 2024. PMID: 38802556. doi:10.1007/s00198-024-07134-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。